Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Indices trade positively
Mon, 16 Feb 11:30 am

After opening the day on a positive note, Indian equity markets have continued to witness buying interest during the previous two hours of trade. Realty and FMCG stocks are the leading gainers. Banking and pharma stocks are the leading losers.

The BSE-Sensex is up by 70 points and NSE-Nifty is up by 17 points. BSE Mid Cap index and BSE Small Cap index are trading up by 0.1%. The rupee is trading at 62.18 to the US dollar.

Majority of the Indian pharmaceutical stocks are trading in the green. Wockhardt Ltd and Ipca labs are the leading gainers while Ranbaxy and Sun Pharma are trading the weakest. According to a leading financial daily, Cipla has been awarded a tender worth Rs 11.7 bn for antiretroviral drugs by The Global Fund to Fight AIDS, Tuberculosis and Malaria. Cipla has been selected as a 'panel supplier' under a supplier partnership agreement. The contract is effective from January 1 and will run for three years. The supplies will begin from the fourth quarter of FY15. The antiretroviral drugs will be manufactured in Cipla's facilities in India.

Mining stocks are trading on a positive note. Sesa Sterlite and Hindustan Zinc are the leading gainers. According to a leading financial daily, Hindalco Industries has bagged the Kathautia coal block in Jharkhand for Rs 28.6 bn a tonne on the second day of coal auction. This would imply that the company would pay Rs 2.2 bn a year and Rs 68 bn for a period of 30 years. The block is for end-use in the unregulated sector - iron, steel, cement and captive power generation. GMR and Reliance Cement bagged one mine each yesterday for an estimated Rs 13.7 bn and Rs 7.9 bn respectively. Hindalco is trading up by 0.6% on the BSE.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian Indices trade positively". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.